FLOWER MOUND, TX / ACCESSWIRE / October 26, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), exclusive manufacturer and distributor of plant-based MiteXstream^TM biopesticide, announced today that it has filled its National Sales General Manager opening with the hiring of experienced sales veteran, Rich Forbis. Mr. Forbis has been charged with implementing and overseeing the company's sales and marketing strategies for MiteXstream^TM, BBBT's disruptive plant-based EPA certified biopesticide.

"I have known and worked with Rich on other projects since the '80s, and I most pleased that he shares our vision for the heights that we can take MiteXstream^TM," said Fabian Deneault, President of BBBT. "I am confident that Rich has the experience, contacts and, most-importantly, the work ethic to do a fantastic job for our company."

When asked for comment, Mr. Forbis stated, "I am excited to join the MiteXstream^TM team. I am grateful for the opportunity to help grow the company to it's true potential. I believe my business contacts will help access the huge potential of MiteXstream^TM in U.S. markets, particularly as Cannabis is increasingly legalized in the states."

Background. Rich Forbis was born and raised in beautiful Western Montana. He attended the University of Montana in Missoula, earning a B.A. degree in Radio and Television. Mr. Forbis has over 30 years of sales and marketing experience working for Anderson Radio Broadcasting and KOFI Radio in Kalispell, Montana. He has also served as the Community Outreach Coordinator and Public Relations Director at Providence St. Joseph Medical Center in Polson, Montana. As an active, long-time member of the business community in Western Montana, Mr. Forbis has served on the Polson Chamber of Commerce Board of Directors for three separate terms and was elected Chamber President in 1993, 2013 and 2018. Mr. Forbis is also an active member in the community at large, including his service as tournament director of the Flathead Lake 3-on-3 Basketball Tournament.

Online Availability. Through www.MiteXstream.com, MiteXstream^TM is available for sale to customers located in Colorado, Oregon, Wyoming, Nevada, Montana, Oklahoma, Massachusetts, New Jersey, Missouri, Pennsylvania, Utah, Kentucky and Delaware, with pending applications in all remaining states, except California, the application for which is nearing completion.

For news and updates, shareholders, prospective investors and prospective business partners are encouraged to follow @BBBT_Corporate on Twitter ( https://twitter.com/BBBT_Corporate ). Also visit BBBT's corporate website, https://blackbirdbiotech.com, for additional information about the company.

About BBBT

Black Bird Biotech is positioned to exploit market segments with powerful, re-imagined biotech products. Its EPA-registered biopesticide, MiteXstream^TM, eradicates mites and similar pests, including spider mites (a lethal pest in cannabis, grapes, hops, coffee, strawberries and many other agricultural crops), and eliminates molds and mildews. MiteXstream^TM is a pesticide, but it is not a poison - it's a pesticide re-imagined. The MiteXstream^TM Edge: use through the day of harvest without concern for residual "pesticide" violations, including in state cannabis testing. MiteXstream^TM is the foundational element of the company that carries vast potential worldwide as a highly effective, safe and extremely cost-effective replacement for many traditional "poisonous" pesticides.

Forward Looking Statements:

This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

CONTACT:
Eric Newlan
Vice President
833-223-4204
eric@newlan.com
www.blackbirdbiotech.com

SOURCE: Black Bird Biotech, Inc.

View source version on accesswire.com:
https://www.accesswire.com/669627/Black-Bird-Biotech-Announces-Hiring-of-National-Sales-General-Manager-for-MiteXstreamTM-Sales-Veteran-to-Lead-US-Sales-and-Marketing-Effort